Sientra (SIEN) Misses Q4 EPS Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Sientra (SIEN) Acquires Rights to bioCorneum Silicone Gel Scar Management Therapy
March 9, 2016 4:22 PM ESTSientra, Inc. (NASDAQ: SIEN) today announced the acquisition from Enaltus, LLC of the exclusive U.S. rights to bioCorneum®, an advanced silicone gel scar management products, for $7.0 million in cash.
Jeffrey Nugent, Chairman and Chief Executive Officer of Sientra, said, Consistent with our stated business development objectives, this acquisition further leverages our highly experienced PSC sales force by adding a differentiated and complementary product that serves the needs of board-certified plastic surgeons while diversifying our business mix. We have received very positive feedback from our customers who are both current and potential... More
